The ambulatory infusion center (AIC) market is growing significantly due to the need for ambulatory care, rising incidence of chronic diseases, and advancements of medical technologies. Ambulatory infusion centers provide specialized infusion therapy to the patient by way of the administration of biologics, chemotherapy, immunotherapy, etc. through intravenous infusion in a non-inpatient setting. The market is growing with the increasing need for cost-effective treatment that is out of the hospital setup.
The increasing inclination toward homecare or ambulatory care, cost-effectiveness of the AIC as compared to the hospital environment, and the infusion of technologies that improve patient experience and treatment outcome are the factors driving the ambulatory infusion centers market.
Governments’ efforts to enhance the accessibility of healthcare and ease of pressure on the hospitals also support the market’s expansion. Furthermore, the market is witnessing alliances between healthcare providers and drug manufacturers to improve the delivery of treatment.
The global ambulatory infusion centers (AICs) market saw significant growth in the last couple of years due to the growing need for infusion therapy at the outpatient care level, e.g., immunotherapy, biologics, chemotherapy. Ambulatory infusion centers are a cost-effective and convenient care solution as compared to infusion therapy at the hospital care level that is less inconvenient to the patient.
The increasing incidence of chronic diseases like autoimmune diseases, diabetes, and cancers that require prolonged infusion therapy are key drivers to the market growth. Ambulatory infusion centers allow the patient to have shorter waiting time, increased convenience, and personalized care away from the hospital setting. Besides, ambulatory infusion centers are less expensive as compared to traditional inpatient care that is appealing to areas with growing healthcare spending.
Technological advancements like telemedicine integration and patient monitor systems are also contributing to the growth of the market. These technologies enhance the quality of treatment, the patient's safety, and the quality of service delivery overall.
Trends within the market are also being fueled by increasing partnerships and acquisitions between healthcare providers and infusion service providers. These are contributing to the expansion of service networks to deliver increased access to the specialized centers.
| Attribute | Detail |
|---|---|
| Ambulatory Infusion Centers Market Drivers |
|
The increasing number of chronic diseases such as cancer, autoimmune diseases, and diabetes is a major driver of the ambulatory infusion centers (AICs) market. These diseases are commonly treated with extended infusion therapy such as chemotherapy, immunotherapy, and biologics that are best delivered at specialized out clinics instead of hospital treatment.
With the growing number of chronic diseases all over the world, the demand is growing for cost-effective and convenient infusion therapy with the ambulatory infusion centers being a cost-effective solution to hospital treatment.
For instance, the incidence of cancers is growing at a higher rate globally with the World Health Organization predicting that the number of cancers will have risen to 29.5 million by 2040. The number of cancer outpatients is contributing to the need for regular infusion of chemotherapy that can easily be provided at the AICs. Autoimmune conditions such as rheumatoid arthritis also require biologic infusions that are contributing to the need to infuse outpatients.
Chronic conditions have their outpatients that are being treated at the AICs at a growing rate due to the shorter time of waiting as compared to the hospital setup. In the U.S., the trend is being experienced with healthcare providers providing increasingly specialized outpatients to accommodate the growing need that is contributing to the expansion of the market.
Ambulatory care is the ongoing trend driven by the need to have cost-effective and convenient healthcare solutions. Ambulatory infusion centers provide a cost-effective solution to the traditionally costly hospital stays with the delivery of quality and specialized infusion therapy at a much lower cost. Both - the healthcare providers and the patients are attracted to this cost-effectiveness, especially among the major healthcare spending nations.
For instance, within the U.S., the delivery of care service by the ambulatory infusion centers (AIC) is increasingly the choice due to the escalating cost of healthcare and insurance policy reform. The payment models introduced by the Centers for Medicare and Medicaid Services (CMS) favor the treatment by ambulatory infusion centers (AIC), making financial sense to have the ambulatory infusion centers (AIC) set up by the providers.
Overburdened hospitals also benefit by referring infusion patients to the centers to ease their operational pressure. Convenience of avoiding the long queues and the hospital-related complications like infection also entices the patient to the ambulatory infusion centers (AIC).
The growing role of the ambulatory infusion centers (AIC) by the private sector entities like InfuSystem and the Outpatient Infusion Center is a reflection of the increasing trend of prioritizing the infusion service delivery by the ambulatory setting to serve the needs of the market.
Among the other disease specialties, the oncology segment is the leader of the ambulatory infusion centers market globally and is forecast to lead between 2024 and 2035. It is driven predominantly by the increasing incidence of cancer all over the world that needs regular and prolonged infusion therapy such as chemotherapy, immunotherapy, and targeted therapy.
AIC provides a less expensive, convenient, and easily accessible setting to the infusions as compared to the traditional hospital setting, thereby increasing the popularity of ambulatory care among outpatients with cancers.
For instance, the incidence of cancers is increasing globally with a record 19 million new cancers being registered in 2020 by the World Health Organization. With the treatment of many cancers being a cornerstone of care with the administration of chemotherapy, the requirement of centers that can provide treatment with ease and convenience is increasing.
Infusion therapy, particularly that of oncology conditions, is usually associated with regular visits spanning a considerable duration of time, with ambulatory infusion centers being the go-to choice of treatment centers among cancer patients due to the convenience they provide to the patient with increased flexibility while eliminating the hassle of prolonged hospital stays.
| Attribute | Detail |
|---|---|
| Leading Region | North America |
According to the latest ambulatory infusion centers market trends, the highest percentage of the ambulatory infusion centers (AICs) market globally is likely to remain with North America in 2024 due to a number of key drivers such as a well-developed base of healthcare infrastructure, highly advanced medical technologies, and strong prevalence of diseases like autoimmune diseases, diabetes, and cancers.
The region's extensive healthcare expenditures, along with the government's supportive insurance reimbursements, is a catalyst to the ambulatory infusion care uptake at a quick pace, making the region the market key player. For instance, the United States is a key driver to the North America’s market share due to the country's extensive healthcare infrastructure base and the increasing need for ambulatory care service provisions.
Ambulatory infusion centers are a cost-effective solution with ease of access as compared to traditional hospital care, and various healthcare providers of the U.S. have been expanding their ambulatory care centers networks to cater to the increasing need for infusion therapy. In addition to this, Medicare and the other insurance providers increasingly reimburse infusion therapy at the ambulatory care centers, making the latter a cost-effective solution to the patient base as well as healthcare centers.
For example, big infusion service providers like InfuSystem of the U.S. and the U.S.-based outpatient infusion centers are expanding their presence to cater to the increasing demand for biologics, chemotherapy, and the other infusion therapy. The trend of treatment on an outpatient basis is also being driven by a significant level of patients’ acceptance and awareness regarding receiving less painful treatment that is quicker as compared to the hospital setting.
Key players operating in the global ambulatory infusion centers market are investing in various technologies such as 3D printing and CAD/CAM in order to design and manufacture dental restorations to unrivaled standards of precision and personalization. Moreover, they are working on developing restorative procedures such as digital orthodontics in order to drive greater productivity and patient outcomes.
Flexcare Infusion Centers, Hawaii Medical Service Association, Pure Infusion Suites, National Infusion Center Association, TwelveStone Health Partners, Richmond University Medical Center, CitusHealth, Valley Health System, Cedars-Sinai, Arnot Health, PharmaScript Naval Medical Center Portsmouth, Cheyenne Regional Medical Center, Pacific Medical Centers, ChristianaCare are some of the leading key players operating in the global ambulatory infusion centers industry.
Each of these players has been profiled in the ambulatory infusion centers market research report based on parameters such as company overview, financial overview, business strategies, product portfolio, business segments, and recent developments.
| Attribute | Detail |
|---|---|
| Size in 2024 | US$ 20.3 Bn |
| Forecast Value in 2035 | US$ 52.3 Bn |
| CAGR | 8.9% |
| Forecast Period | 2025-2035 |
| Historical Data Available for | 2020-2024 |
| Quantitative Units | US$ Bn |
| Ambulatory Infusion Centers Market Analysis | It includes segment analysis as well as regional level analysis. Moreover, qualitative analysis includes drivers, restraints, opportunities, key trends, value chain analysis, and key trend analysis. |
| Competition Landscape |
|
| Format | Electronic (PDF) + Excel |
| Segmentation |
|
| Regions Covered |
|
| Countries Covered |
|
| Companies Profiled |
|
| Customization Scope | Available upon request |
| Pricing | Available upon request |
The ambulatory infusion centers market was valued at US$ 20.3 Bn in 2024.
The ambulatory infusion centers market is projected to cross US$ 52.3 Bn by the end of 2035.
Rise in prevalence of chronic diseases, shift toward outpatient care, and cost-efficiency.
The CAGR is anticipated to be 8.9% from 2025 to 2035.
North America is expected to account for the largest share from 2025 to 2035.
Flexcare Infusion Centers, Hawaii Medical Service Association, Pure Infusion Suites, National Infusion Center Association, TwelveStone Health Partners, Richmond University Medical Center, CitusHealth, Valley Health System, Cedars-Sinai, Arnot Health, PharmaScript Naval Medical Center Portsmouth, Cheyenne Regional Medical Center, Pacific Medical Centers, ChristianaCare, and Others.
1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Global Ambulatory Infusion Centers Market
4. Market Overview
4.1. Introduction
4.1.1. Segment Definition
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. Global Ambulatory Infusion Centers Market Analysis and Forecast, 2020-2035
4.4.1. Market Revenue Projections (US$ Bn)
5. Key Insights
5.1. Key Industry Events
5.2. PESTEL Analysis
5.3. Regulatory Scenario by Key Countries/Region
5.4. PORTER’s Five Forces Analysis
5.5. Technological Advancements
5.6. Unmet Needs of the Market
5.7. Healthcare Spending’s by Country
6. Global Ambulatory Infusion Centers Market Analysis and Forecast, by Type of Center
6.1. Introduction & Definition
6.2. Key Findings/Developments
6.3. Market Value Forecast, by Type of Center, 2020-2035
6.3.1. Hospital-based Infusion Centers
6.3.2. Physician-based Infusion Centers
6.3.3. Independent Infusion Centers
6.4. Market Attractiveness Analysis, by Type of Center
7. Global Ambulatory Infusion Centers Market Analysis and Forecast, by Therapy Type
7.1. Introduction & Definition
7.2. Key Findings/Developments
7.3. Market Value Forecast, by Therapy Type, 2020-2035
7.3.1. Antibiotics
7.3.2. Blood Products
7.3.3. Nutritional Products
7.3.4. Immunosuppressants
7.3.5. Immunostimulants
7.3.6. Monoclonal Antibodies
7.3.7. Immunoglobulin Therapy
7.3.8. Others
7.4. Market Attractiveness Analysis, by Therapy Type
8. Global Ambulatory Infusion Centers Market Analysis and Forecast, by Disease Specialties
8.1. Introduction & Definition
8.2. Key Findings/Developments
8.3. Market Value Forecast, by Disease Specialties, 2020-2035
8.3.1. Oncology
8.3.2. Pulmonology
8.3.3. Neurology
8.3.4. Gastrointestinal
8.3.5. Immunology
8.3.6. Cardiology
8.3.7. Others
8.4. Market Attractiveness Analysis, by Disease Specialties
9. Global Ambulatory Infusion Centers Market Analysis and Forecast, by Region
9.1. Key Findings
9.2. Market Value Forecast, by Region, 2020-2035
9.2.1. North America
9.2.2. Europe
9.2.3. Asia Pacific
9.2.4. Latin America
9.2.5. Middle East & Africa
9.3. Market Attractiveness Analysis, by Region
10. North America Ambulatory Infusion Centers Market Analysis and Forecast
10.1. Introduction
10.1.1. Key Findings
10.2. Market Value Forecast, by Type of Center, 2020-2035
10.2.1. Hospital-based Infusion Centers
10.2.2. Physician-based Infusion Centers
10.2.3. Independent Infusion Centers
10.3. Market Value Forecast, by Therapy Type, 2020-2035
10.3.1. Antibiotics
10.3.2. Blood Products
10.3.3. Nutritional Products
10.3.4. Immunosuppressants
10.3.5. Immunostimulants
10.3.6. Monoclonal Antibodies
10.3.7. Immunoglobulin Therapy
10.3.8. Others
10.4. Market Value Forecast, by Disease Specialties, 2020-2035
10.4.1. Oncology
10.4.2. Pulmonology
10.4.3. Neurology
10.4.4. Gastrointestinal
10.4.5. Immunology
10.4.6. Cardiology
10.4.7. Others
10.5. Market Value Forecast, by Country, 2020-2035
10.5.1. U.S.
10.5.2. Canada
10.6. Market Attractiveness Analysis
10.6.1. By Type of Center
10.6.2. By Therapy Type
10.6.3. By Disease Specialties
10.6.4. By Country
11. Europe Ambulatory Infusion Centers Market Analysis and Forecast
11.1. Introduction
11.1.1. Key Findings
11.2. Market Value Forecast, by Type of Center, 2020-2035
11.2.1. Hospital-based Infusion Centers
11.2.2. Physician-based Infusion Centers
11.2.3. Independent Infusion Centers
11.3. Market Value Forecast, by Therapy Type, 2020-2035
11.3.1. Antibiotics
11.3.2. Blood Products
11.3.3. Nutritional Products
11.3.4. Immunosuppressants
11.3.5. Immunostimulants
11.3.6. Monoclonal Antibodies
11.3.7. Immunoglobulin Therapy
11.3.8. Others
11.4. Market Value Forecast, by Disease Specialties, 2020-2035
11.4.1. Oncology
11.4.2. Pulmonology
11.4.3. Neurology
11.4.4. Gastrointestinal
11.4.5. Immunology
11.4.6. Cardiology
11.4.7. Others
11.5. Market Value Forecast, by Country/Sub-region, 2020-2035
11.5.1. Germany
11.5.2. UK
11.5.3. France
11.5.4. Italy
11.5.5. Spain
11.5.6. Rest of Europe
11.6. Market Attractiveness Analysis
11.6.1. By Type of Center
11.6.2. By Therapy Type
11.6.3. By Disease Specialties
11.6.4. By Country/Sub-region
12. Asia Pacific Ambulatory Infusion Centers Market Analysis and Forecast
12.1. Introduction
12.1.1. Key Findings
12.2. Market Value Forecast, by Type of Center, 2020-2035
12.2.1. Hospital-based Infusion Centers
12.2.2. Physician-based Infusion Centers
12.2.3. Independent Infusion Centers
12.3. Market Value Forecast, by Therapy Type, 2020-2035
12.3.1. Antibiotics
12.3.2. Blood Products
12.3.3. Nutritional Products
12.3.4. Immunosuppressants
12.3.5. Immunostimulants
12.3.6. Monoclonal Antibodies
12.3.7. Immunoglobulin Therapy
12.3.8. Others
12.4. Market Value Forecast, by Disease Specialties, 2020-2035
12.4.1. Oncology
12.4.2. Pulmonology
12.4.3. Neurology
12.4.4. Gastrointestinal
12.4.5. Immunology
12.4.6. Cardiology
12.4.7. Others
12.5. Market Value Forecast, by Country/Sub-region, 2020-2035
12.5.1. China
12.5.2. Japan
12.5.3. India
12.5.4. Australia & New Zealand
12.5.5. Rest of Asia Pacific
12.6. Market Attractiveness Analysis
12.6.1. By Type of Center
12.6.2. By Therapy Type
12.6.3. By Disease Specialties
12.6.4. By Country/Sub-region
13. Latin America Ambulatory Infusion Centers Market Analysis and Forecast
13.1. Introduction
13.1.1. Key Findings
13.2. Market Value Forecast, by Type of Center, 2020-2035
13.2.1. Hospital-based Infusion Centers
13.2.2. Physician-based Infusion Centers
13.2.3. Independent Infusion Centers
13.3. Market Value Forecast, by Therapy Type, 2020-2035
13.3.1. Antibiotics
13.3.2. Blood Products
13.3.3. Nutritional Products
13.3.4. Immunosuppressants
13.3.5. Immunostimulants
13.3.6. Monoclonal Antibodies
13.3.7. Immunoglobulin Therapy
13.3.8. Others
13.4. Market Value Forecast, by Disease Specialties, 2020-2035
13.4.1. Oncology
13.4.2. Pulmonology
13.4.3. Neurology
13.4.4. Gastrointestinal
13.4.5. Immunology
13.4.6. Cardiology
13.4.7. Others
13.5. Market Value Forecast, by Country/Sub-region, 2020-2035
13.5.1. Brazil
13.5.2. Mexico
13.5.3. Rest of Latin America
13.6. Market Attractiveness Analysis
13.6.1. By Type of Center
13.6.2. By Therapy Type
13.6.3. By Disease Specialties
13.6.4. By Country/Sub-region
14. Middle East & Africa Ambulatory Infusion Centers Market Analysis and Forecast
14.1. Introduction
14.1.1. Key Findings
14.2. Market Value Forecast, by Type of Center, 2020-2035
14.2.1. Hospital-based Infusion Centers
14.2.2. Physician-based Infusion Centers
14.2.3. Independent Infusion Centers
14.3. Market Value Forecast, by Therapy Type, 2020-2035
14.3.1. Antibiotics
14.3.2. Blood Products
14.3.3. Nutritional Products
14.3.4. Immunosuppressants
14.3.5. Immunostimulants
14.3.6. Monoclonal Antibodies
14.3.7. Immunoglobulin Therapy
14.3.8. Others
14.4. Market Value Forecast, by Disease Specialties, 2020-2035
14.4.1. Oncology
14.4.2. Pulmonology
14.4.3. Neurology
14.4.4. Gastrointestinal
14.4.5. Immunology
14.4.6. Cardiology
14.4.7. Others
14.5. Market Value Forecast, by Country/Sub-region, 2020-2035
14.5.1. GCC Countries
14.5.2. South Africa
14.5.3. Rest of Middle East & Africa
14.6. Market Attractiveness Analysis
14.6.1. By Type of Center
14.6.2. By Therapy Type
14.6.3. By Disease Specialties
14.6.4. By Country/Sub-region
15. Competition Landscape
15.1. Market Player - Competition Matrix (By Tier and Size of companies)
15.2. Market Share Analysis, by Company (2023)
15.3. Company Profiles
15.3.1. Flexcare Infusion Centers
15.3.1.1. Company Overview
15.3.1.2. Financial Overview
15.3.1.3. Product Portfolio
15.3.1.4. Business Strategies
15.3.1.5. Recent Developments
15.3.2. Hawaii Medical Service Association
15.3.2.1. Company Overview
15.3.2.2. Financial Overview
15.3.2.3. Product Portfolio
15.3.2.4. Business Strategies
15.3.2.5. Recent Developments
15.3.3. Pure Infusion Suites
15.3.3.1. Company Overview
15.3.3.2. Financial Overview
15.3.3.3. Product Portfolio
15.3.3.4. Business Strategies
15.3.3.5. Recent Developments
15.3.4. National Infusion Center Association
15.3.4.1. Company Overview
15.3.4.2. Financial Overview
15.3.4.3. Product Portfolio
15.3.4.4. Business Strategies
15.3.4.5. Recent Developments
15.3.5. TwelveStone Health Partners
15.3.5.1. Company Overview
15.3.5.2. Financial Overview
15.3.5.3. Product Portfolio
15.3.5.4. Business Strategies
15.3.5.5. Recent Developments
15.3.6. Richmond University Medical Center
15.3.6.1. Company Overview
15.3.6.2. Financial Overview
15.3.6.3. Product Portfolio
15.3.6.4. Business Strategies
15.3.6.5. Recent Developments
15.3.7. CitusHealth
15.3.7.1. Company Overview
15.3.7.2. Financial Overview
15.3.7.3. Product Portfolio
15.3.7.4. Business Strategies
15.3.7.5. Recent Developments
15.3.8. Valley Health System
15.3.8.1. Company Overview
15.3.8.2. Financial Overview
15.3.8.3. Product Portfolio
15.3.8.4. Business Strategies
15.3.8.5. Recent Developments
15.3.9. Cedars-Sinai
15.3.9.1. Company Overview
15.3.9.2. Financial Overview
15.3.9.3. Product Portfolio
15.3.9.4. Business Strategies
15.3.9.5. Recent Developments
15.3.10. Arnot Health
15.3.10.1. Company Overview
15.3.10.2. Financial Overview
15.3.10.3. Product Portfolio
15.3.10.4. Business Strategies
15.3.10.5. Recent Developments
15.3.11. PharmaScript
15.3.11.1. Company Overview
15.3.11.2. Financial Overview
15.3.11.3. Product Portfolio
15.3.11.4. Business Strategies
15.3.11.5. Recent Developments
15.3.12. Naval Medical Center Portsmouth
15.3.12.1. Company Overview
15.3.12.2. Financial Overview
15.3.12.3. Product Portfolio
15.3.12.4. Business Strategies
15.3.12.5. Recent Developments
15.3.13. Cheyenne Regional Medical Center
15.3.13.1. Company Overview
15.3.13.2. Financial Overview
15.3.13.3. Product Portfolio
15.3.13.4. Business Strategies
15.3.13.5. Recent Developments
15.3.14. Pacific Medical Centers
15.3.14.1. Company Overview
15.3.14.2. Financial Overview
15.3.14.3. Product Portfolio
15.3.14.4. Business Strategies
15.3.14.5. Recent Developments
15.3.15. ChristianaCare
15.3.15.1. Company Overview
15.3.15.2. Financial Overview
15.3.15.3. Product Portfolio
15.3.15.4. Business Strategies
15.3.15.5. Recent Developments
List of Tables
Table 01: Global Ambulatory Infusion Centers Market Value (US$ Bn) Forecast, by Type of Center, 2020-2035
Table 02: Global Ambulatory Infusion Centers Market Value (US$ Bn) Forecast, By Therapy Type, 2020-2035
Table 03: Global Ambulatory Infusion Centers Market Value (US$ Bn) Forecast, by Disease Specialties, 2020-2035
Table 04: Global Ambulatory Infusion Centers Market Value (US$ Bn) Forecast, By Region, 2020-2035
Table 05: North America - Ambulatory Infusion Centers Market Value (US$ Bn) Forecast, by Country, 2020-2034
Table 06: North America Ambulatory Infusion Centers Market Value (US$ Bn) Forecast, by Type of Center, 2020-2035
Table 07: North America Ambulatory Infusion Centers Market Value (US$ Bn) Forecast, By Therapy Type, 2020-2035
Table 08: North America Ambulatory Infusion Centers Market Value (US$ Bn) Forecast, by Disease Specialties, 2020-2035
Table 09: Europe - Ambulatory Infusion Centers Market Value (US$ Bn) Forecast, by Country/Sub-region, 2020-2034
Table 10: Europe Ambulatory Infusion Centers Market Value (US$ Bn) Forecast, by Type of Center, 2020-2035
Table 11: Europe Ambulatory Infusion Centers Market Value (US$ Bn) Forecast, By Therapy Type, 2020-2035
Table 12: Europe Ambulatory Infusion Centers Market Value (US$ Bn) Forecast, by Disease Specialties, 2020-2035
Table 13: Asia Pacific - Ambulatory Infusion Centers Market Value (US$ Bn) Forecast, by Country/Sub-region, 2020-2034
Table 14: Asia Pacific Ambulatory Infusion Centers Market Value (US$ Bn) Forecast, by Type of Center, 2020-2035
Table 15: Asia Pacific Ambulatory Infusion Centers Market Value (US$ Bn) Forecast, By Therapy Type, 2020-2035
Table 16: Asia Pacific Ambulatory Infusion Centers Market Value (US$ Bn) Forecast, by Disease Specialties, 2020-2035
Table 17: Latin America - Ambulatory Infusion Centers Market Value (US$ Bn) Forecast, by Country/Sub-region, 2020-2034
Table 18: Latin America Ambulatory Infusion Centers Market Value (US$ Bn) Forecast, by Type of Center, 2020-2035
Table 19: Latin America Ambulatory Infusion Centers Market Value (US$ Bn) Forecast, By Therapy Type, 2020-2035
Table 20: Latin America Ambulatory Infusion Centers Market Value (US$ Bn) Forecast, by Disease Specialties, 2020-2035
Table 21: Middle East & Africa - Ambulatory Infusion Centers Market Value (US$ Bn) Forecast, by Country/Sub-region, 2020-2034
Table 22: Middle East and Africa Ambulatory Infusion Centers Market Value (US$ Bn) Forecast, by Type of Center, 2020-2035
Table 23: Middle East and Africa Ambulatory Infusion Centers Market Value (US$ Bn) Forecast, By Therapy Type, 2020-2035
Table 24: Middle East and Africa Ambulatory Infusion Centers Market Value (US$ Bn) Forecast, by Disease Specialties, 2020-2035
List of Figures
Figure 01: Global Ambulatory Infusion Centers Market Value Share Analysis, by Type of Center, 2024 and 2035
Figure 02: Global Ambulatory Infusion Centers Market Attractiveness Analysis, by Type of Center, 2025-2035
Figure 03: Global Ambulatory Infusion Centers Market Revenue (US$ Bn), by Hospital-based Infusion Centers, 2020-2035
Figure 04: Global Ambulatory Infusion Centers Market Revenue (US$ Bn), by Physician-based Infusion Centers, 2020-2035
Figure 05: Global Ambulatory Infusion Centers Market Revenue (US$ Bn), by Independent Infusion Centers, 2020-2035
Figure 06: Global Ambulatory Infusion Centers Market Value Share Analysis, by Therapy Type, 2024 and 2035
Figure 07: Global Ambulatory Infusion Centers Market Attractiveness Analysis, by Therapy Type, 2025-2035
Figure 08: Global Ambulatory Infusion Centers Market Revenue (US$ Bn), by Antibiotics, 2020-2035
Figure 09: Global Ambulatory Infusion Centers Market Revenue (US$ Bn), by Blood Products, 2020-2035
Figure 10: Global Ambulatory Infusion Centers Market Revenue (US$ Bn), by Nutritional Products, 2020-2035
Figure 11: Global Ambulatory Infusion Centers Market Revenue (US$ Bn), by Immunosuppressants, 2020-2035
Figure 12: Global Ambulatory Infusion Centers Market Revenue (US$ Bn), by Immunostimulants, 2020-2035
Figure 13: Global Ambulatory Infusion Centers Market Revenue (US$ Bn), by Monoclonal antibodies, 2020-2035
Figure 14: Global Ambulatory Infusion Centers Market Revenue (US$ Bn), by Immunoglobulin Therapy, 2020-2035
Figure 15: Global Ambulatory Infusion Centers Market Revenue (US$ Bn), by Others, 2020-2035
Figure 16: Global Ambulatory Infusion Centers Market Value Share Analysis, by Disease Specialties, 2024 and 2035
Figure 17: Global Ambulatory Infusion Centers Market Attractiveness Analysis, by Disease Specialties, 2025-2035
Figure 18: Global Ambulatory Infusion Centers Market Revenue (US$ Bn), by Oncology, 2020-2035
Figure 19: Global Ambulatory Infusion Centers Market Revenue (US$ Bn), by Pulmonology, 2020-2035
Figure 20: Global Ambulatory Infusion Centers Market Revenue (US$ Bn), by Neurology, 2020-2035
Figure 21: Global Ambulatory Infusion Centers Market Revenue (US$ Bn), by Gastrointestinal, 2020-2035
Figure 22: Global Ambulatory Infusion Centers Market Revenue (US$ Bn), by Immunology, 2020-2035
Figure 23: Global Ambulatory Infusion Centers Market Revenue (US$ Bn), by Cardiology, 2020-2035
Figure 24: Global Ambulatory Infusion Centers Market Revenue (US$ Bn), by Others, 2020-2035
Figure 25: Global Ambulatory Infusion Centers Market Value Share Analysis, By Region, 2024 and 2035
Figure 26: Global Ambulatory Infusion Centers Market Attractiveness Analysis, By Region, 2025-2035
Figure 27: North America - Ambulatory Infusion Centers Market Value (US$ Bn) Forecast, 2020-2035
Figure 28: North America - Ambulatory Infusion Centers Market Value Share Analysis, by Country, 2024 and 2035
Figure 29: North America - Ambulatory Infusion Centers Market Attractiveness Analysis, by Country, 2025-2035
Figure 30: North America Ambulatory Infusion Centers Market Value Share Analysis, by Type of Center, 2024 and 2035
Figure 31: North America Ambulatory Infusion Centers Market Attractiveness Analysis, by Type of Center, 2025-2035
Figure 32: North America Ambulatory Infusion Centers Market Value Share Analysis, by Therapy Type, 2024 and 2035
Figure 33: North America Ambulatory Infusion Centers Market Attractiveness Analysis, by Therapy Type, 2025-2035
Figure 34: North America Ambulatory Infusion Centers Market Value Share Analysis, by Disease Specialties, 2024 and 2035
Figure 35: North America Ambulatory Infusion Centers Market Attractiveness Analysis, by Disease Specialties, 2025-2035
Figure 36: Europe Ambulatory Infusion Centers Market Value (US$ Bn) Forecast, 2020-2035
Figure 37: Europe - Ambulatory Infusion Centers Market Value Share Analysis, by Country/Sub-region, 2024 and 2035
Figure 38: Europe - Ambulatory Infusion Centers Market Attractiveness Analysis, by Country/Sub-region, 2025-2035
Figure 39: Europe Ambulatory Infusion Centers Market Value Share Analysis, by Type of Center, 2024 and 2035
Figure 40: Europe Ambulatory Infusion Centers Market Attractiveness Analysis, by Type of Center, 2025-2035
Figure 41: Europe Ambulatory Infusion Centers Market Value Share Analysis, By Therapy Type, 2024 and 2035
Figure 42: Europe Ambulatory Infusion Centers Market Attractiveness Analysis, By Therapy Type, 2025-2035
Figure 43: Europe Ambulatory Infusion Centers Market Value Share Analysis, by Disease Specialties, 2024 and 2035
Figure 44: Europe Ambulatory Infusion Centers Market Attractiveness Analysis, by Disease Specialties, 2025-2035
Figure 45: Asia Pacific - Ambulatory Infusion Centers Market Value (US$ Bn) Forecast, 2020-2035
Figure 46: Asia Pacific - Ambulatory Infusion Centers Market Value Share Analysis, by Country/Sub-region, 2024 and 2035
Figure 47: Asia Pacific - Ambulatory Infusion Centers Market Attractiveness Analysis, by Country/Sub-region, 2025-2035
Figure 48: Asia Pacific Ambulatory Infusion Centers Market Value Share Analysis, by Type of Center, 2024 and 2035
Figure 49: Asia Pacific Ambulatory Infusion Centers Market Attractiveness Analysis, by Type of Center, 2025-2035
Figure 50: Asia Pacific Ambulatory Infusion Centers Market Value Share Analysis, By Therapy Type, 2024 and 2035
Figure 51: Asia Pacific Ambulatory Infusion Centers Market Attractiveness Analysis, By Therapy Type, 2025-2035
Figure 52: Asia Pacific Ambulatory Infusion Centers Market Value Share Analysis, by Disease Specialties, 2024 and 2035
Figure 53: Asia Pacific Ambulatory Infusion Centers Market Attractiveness Analysis, by Disease Specialties, 2025-2035
Figure 54: Latin America - Ambulatory Infusion Centers Market Value (US$ Bn) Forecast, 2020-2035
Figure 55: Latin America - Ambulatory Infusion Centers Market Value Share Analysis, by Country/Sub-region, 2024 and 2035
Figure 56: Latin America - Ambulatory Infusion Centers Market Attractiveness Analysis, by Country/Sub-region, 2025-2035
Figure 57: Latin America Ambulatory Infusion Centers Market Value Share Analysis, by Type of Center, 2024 and 2035
Figure 58: Latin America Ambulatory Infusion Centers Market Attractiveness Analysis, by Type of Center, 2025-2035
Figure 59: Latin America Ambulatory Infusion Centers Market Value Share Analysis, By Therapy Type, 2024 and 2035
Figure 60: Latin America Ambulatory Infusion Centers Market Attractiveness Analysis, By Therapy Type, 2025-2035
Figure 61: Latin America Ambulatory Infusion Centers Market Value Share Analysis, by Disease Specialties, 2024 and 2035
Figure 62: Latin America Ambulatory Infusion Centers Market Attractiveness Analysis, by Disease Specialties, 2025-2035
Figure 63: Middle East & Africa - Ambulatory Infusion Centers Market Value (US$ Bn) Forecast, 2020-2035
Figure 64: Middle East & Africa - Ambulatory Infusion Centers Market Value Share Analysis, by Country/Sub-region, 2024 and 2035
Figure 65: Middle East & Africa - Ambulatory Infusion Centers Market Attractiveness Analysis, by Country/Sub-region, 2025-2035
Figure 66: Middle East and Africa Ambulatory Infusion Centers Market Value Share Analysis, by Type of Center, 2024 and 2035
Figure 67: Middle East and Africa Ambulatory Infusion Centers Market Attractiveness Analysis, by Type of Center, 2025-2035
Figure 68: Middle East and Africa Ambulatory Infusion Centers Market Value Share Analysis, by Therapy Type, 2024 and 2035
Figure 69: Middle East and Africa Ambulatory Infusion Centers Market Attractiveness Analysis, By Therapy Type, 2025-2035
Figure 70: Middle East and Africa Ambulatory Infusion Centers Market Value Share Analysis, by Disease Specialties, 2024 and 2035
Figure 71: Middle East and Africa Ambulatory Infusion Centers Market Attractiveness Analysis, by Disease Specialties, 2025-2035
Copyright © Transparency Market Research, Inc. All Rights reserved
Trust Online
Ambulatory Infusion Centers Market
